Foresight Acquisition Corp. II
Status: Stalled
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $200.00M |
---|---|
IPO Date | * |
CEO | Michael Balkin |
Left Lead | Cowen |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 18 + 3 + (1*3) |
IPO Sector |
Consumer
Technology-enabled consumer or consumer healthcare |
IPO Geography | Global |
Target Company | TBD |
Deal Announced | TBD |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
FACQ
FACQU
FACQ/W
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Foresight Acquisition Corp. II:
- Structure and cap table
- 6 directors & officers
- 3 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Greg Wasson | 62 | Chairman |
Michael Balkin | 62 | CEO & Director |
Gerald Muizelaar | 46 | CFO |
Judith Sprieser | 67 | Director |
Wanji Walcott | 51 | Director |
Robert Zimmerman | 69 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Cowen | Joint BR | 10,000,000 | units |
William Blair | Joint BR | 10,000,000 | |
20,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
BCMA | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 3 filings.